With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Prostanoids are the most potent therapies for PAH, yet they are underused. Drs. Waxman, Frantz, and Chakinala discuss barriers to their use and when and how to use them.
Evidence shows that hypertension remains poorly controlled throughout the world. Join us, as you are invited to participate in this educational survey to gauge physician practice patterns in the management of hypertension.
Join our experts Drs. Weber, Chappel, Basile, Giles, White, and Izzo as they discuss perspectives from ASH 2011 on improving standard of care for patients with HTN.
Hypertension affects approximately 73 million adults in the U.S. and is one of the most important risk factors for cardiovascular and renal diseases. Dr. Kountz will focus on current hypertension treatment disparities and high-risk patients while providing a thorough exploration of guideline-based management strategies.
Show all
Collapse